Previous Close | 13.91 |
Open | 14.34 |
Bid | 15.07 x 100 |
Ask | 15.19 x 100 |
Day's Range | 14.21 - 15.22 |
52 Week Range | 8.08 - 36.04 |
Volume | |
Avg. Volume | 227,074 |
Market Cap | 320.937M |
Beta (5Y Monthly) | 0.49 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
While it may not be enough for some shareholders, we think it is good to see the Enanta Pharmaceuticals, Inc...
The analysts might have been a bit too bullish on Enanta Pharmaceuticals, Inc. ( NASDAQ:ENTA ), given that the company...
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2024 Earnings Call Transcript February 7, 2024 Enanta Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to Enanta Pharmaceuticals’ Fiscal First Quarter Financial Results Conference Call. At this time, […]